Dexamethasone eye drops show promise in reducing severe vision disease in premature infants

Among the many vulnerabilities of very premature infants, the threat of blindness from abnormal retinal vessel growth has long demanded invasive intervention — laser or injection — in bodies barely ready for the world. A Swedish clinical trial now suggests that a simple, inexpensive steroid eye drop may halve the need for such procedures, offering a gentler path through one of neonatal medicine's most difficult passages. The DROPROP trial, small but carefully conducted, does not yet settle the question — but it opens a door that could, if confirmed, change the standard of care for fragile newb